Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30012201
Basic Information
VIS ID
TVIS30012201
Fusion event
HIV-CRK integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr17
Cytoband
p13.3
Reference genome
GRCh37/hg19
Start
1325702/1422408 (Hg38)
End
1325702/1422408 (Hg38)
Orient
+
Location type
UTR3
Target gene
CRK
miRNAs that regulate target gene
hsa-mir-126-3p
;
hsa-mir-132-3p
;
hsa-mir-125a-5p
;
hsa-mir-215-5p
;
hsa-mir-10a-5p
;
hsa-mir-192-5p
;
hsa-mir-106b-3p
;
hsa-mir-129-1-3p
;
hsa-mir-15b-5p
;
hsa-let-7e-5p
;
hsa-mir-1260b
;
hsa-mir-1257
;
hsa-mir-4320
;
hsa-mir-8485
;
hsa-mir-205-3p
;
hsa-mir-10b-5p
;
hsa-let-7c-5p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-5096
;
hsa-mir-3941
;
hsa-mir-613
;
hsa-mir-206
;
hsa-mir-1-3p
;
hsa-mir-3140-3p
;
hsa-mir-6893-3p
;
hsa-mir-6128
;
hsa-mir-370-3p
;
hsa-mir-6765-3p
;
hsa-mir-3622b-3p
;
hsa-mir-3622a-3p
;
hsa-mir-619-3p
;
hsa-mir-603
;
hsa-mir-362-3p
;
hsa-mir-329-3p
;
hsa-mir-216b-3p
;
hsa-mir-7156-3p
;
hsa-mir-127-5p
;
hsa-mir-4284
;
hsa-mir-7843-3p
;
hsa-mir-1184
;
hsa-mir-1304-3p
;
hsa-mir-6741-3p
;
hsa-mir-4726-3p
;
hsa-mir-6764-5p
;
hsa-mir-1915-3p
;
hsa-mir-6840-3p
;
hsa-mir-6890-3p
;
hsa-mir-1306-5p
;
hsa-mir-509-5p
;
hsa-mir-509-3-5p
;
hsa-mir-4418
;
hsa-mir-30e-3p
;
hsa-mir-30d-3p
;
hsa-mir-30a-3p
;
hsa-mir-6516-5p
;
hsa-mir-1273h-3p
;
hsa-mir-3678-3p
;
hsa-mir-190a-3p
;
hsa-mir-4524b-5p
;
hsa-mir-4524a-5p
;
hsa-mir-298
;
hsa-mir-3163
;
hsa-mir-5680
;
hsa-mir-646
;
hsa-mir-580-5p
;
hsa-mir-410-3p
;
hsa-mir-16-5p
;
hsa-mir-503-5p
;
hsa-mir-6838-5p
;
hsa-mir-15a-5p
;
hsa-mir-195-5p
;
hsa-mir-424-5p
;
hsa-mir-497-5p
;
hsa-mir-9-3p
;
hsa-mir-423-3p
;
hsa-mir-31-3p
;
hsa-mir-502-3p
;
hsa-mir-5590-3p
;
hsa-mir-501-3p
;
hsa-mir-142-5p
;
hsa-mir-4796-3p
;
hsa-mir-3609
;
hsa-mir-548ah-5p
;
hsa-mir-320d
;
hsa-mir-320b
;
hsa-mir-320a
;
hsa-mir-4429
;
hsa-mir-320c
;
hsa-mir-20b-5p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-106a-5p
;
hsa-mir-519d-3p
;
hsa-mir-17-5p
;
hsa-mir-302d-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-520c-3p
;
hsa-mir-520d-3p
;
hsa-mir-302a-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302b-3p
;
hsa-mir-520e
;
hsa-mir-302c-3p
;
hsa-mir-135b-3p
;
hsa-mir-664b-5p
;
hsa-mir-6814-5p
;
hsa-mir-4733-5p
;
hsa-mir-548l
;
hsa-mir-186-5p
;
hsa-mir-548n
;
hsa-mir-6818-5p
;
hsa-mir-5196-5p
;
hsa-mir-4747-5p
;
hsa-mir-6821-3p
;
hsa-mir-6790-3p
;
hsa-mir-4790-3p
;
hsa-mir-4652-3p
;
hsa-mir-640
;
hsa-mir-367-5p
;
hsa-mir-1267
;
hsa-mir-6787-3p
;
hsa-mir-6891-3p
;
hsa-mir-6072
;
hsa-mir-1207-3p
;
hsa-mir-4778-5p
;
hsa-mir-510-5p
;
hsa-mir-512-5p
;
hsa-mir-126-5p
;
hsa-mir-138-2-3p
;
hsa-mir-1910-3p
;
hsa-mir-2110
;
hsa-mir-3065-5p
;
hsa-mir-30c-1-3p
;
hsa-mir-30c-2-3p
;
hsa-mir-3150a-3p
;
hsa-mir-3192-5p
;
hsa-mir-33a-5p
;
hsa-mir-33b-5p
;
hsa-mir-3680-3p
;
hsa-mir-3714
;
hsa-mir-4260
;
hsa-mir-4271
;
hsa-mir-4463
;
hsa-mir-4477a
;
hsa-mir-4487
;
hsa-mir-450a-2-3p
;
hsa-mir-4725-3p
;
hsa-mir-548c-3p
;
hsa-mir-5572
;
hsa-mir-605-3p
;
hsa-mir-6511a-5p
;
hsa-mir-6731-5p
;
hsa-mir-6763-5p
;
hsa-mir-6780b-5p
;
hsa-mir-6788-5p
;
hsa-mir-6810-5p
;
hsa-mir-6857-5p
;
hsa-mir-6878-5p
;
hsa-mir-7-1-3p
;
hsa-mir-7-2-3p
;
hsa-mir-7851-3p
;
hsa-mir-8085
;
hsa-mir-873-3p
;
hsa-mir-95-5p
Nearest miRNA
hsa-mir-3183/Upstream/399849; hsa-mir-10226/Downstream/291495;
Nearest TSS
ENST00000595228/Upstream/22030;
ENST00000570924/Downstream/2065;
Nearest CpG islands
None/Target,
chr17-CpG: 26/Upstream/21813
,
chr17-CpG: 93/Downstream/33238
Nearest cancer related gene
CRK
(OG, No orient, 0)
Upstream sequence
gtgcaccaccacgccgggctaattttttatatctttagcagagatggggtttcactatgttggccaggctggtctcgaactcctgacctcatgatccacc
Downstream sequence
cgcctcggcctcccaaagtgctgggattacagacgtgagccaccgcgcccagccGGTTCAACATTTTTTCAAAGCACTAACCCTACCCCAAATTCATGTA
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Resting CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate